AQR Capital Management
AMRI

AQR Capital Management’s Albany Molecular Research Inc AMRI Stock Holding History

AQR Capital Management’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-13,212
Closed -$230K – 2356
2015
Q3 		$230K Sell
13,212
-5,901
-31% -$120K ﹤0.01% 2020
2015
Q2 		$386K Sell
19,113
-7,307
-28% -$141K ﹤0.01% 1884
2015
Q1 		$465K Sell
26,420
-12,900
-33% -$220K ﹤0.01% 1724
2014
Q4 		$640K Sell
39,320
-18,442
-32% -$338K ﹤0.01% 1850
2014
Q3 		$1.27M Hold
57,762
– – ﹤0.01% 1492
2014
Q2 		$1.16M Sell
57,762
-14,900
-21% -$252K ﹤0.01% 1579
2014
Q1 		$1.35M Buy
72,662
+7,800
+12% +$107K ﹤0.01% 1542
2013
Q4 		$654K Buy
64,862
+361
+0.6% +$4.36K ﹤0.01% 1929
2013
Q3 		$831K Buy
64,501
+7,737
+14% +$95.2K ﹤0.01% 1754
2013
Q2 		$674K Buy
+56,764
New +$615K ﹤0.01% 1764

Other funds holding AMRI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
PIP
Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management's AMRI Position: Q4 2015 in Review

AQR Capital Management sold out of Albany Molecular Research Inc (AMRI) in Q4 2015, closing a stake of 13,212 shares — an estimated $230K sold.

AQR Capital Management first reported a position in AMRI in Q2 2013 and held it in 10 quarters. The position peaked at $1.35M in Q1 2014. 151 funds tracked by Wall St. Rank hold AMRI as of Q4 2015.

  • AQR Capital Management reported no remaining Albany Molecular Research Inc position as of Q4 2015 after selling out during the quarter.
  • AQR Capital Management sold 13,212 Albany Molecular Research Inc shares in Q4 2015, an estimated $230K.
  • AQR Capital Management first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 10 quarters.
  • AQR Capital Management's Albany Molecular Research Inc position peaked at $1.35M in Q1 2014.
  • 151 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q4 2015.

Based on AQR Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.